Early changes on electroencephalography in natalizumab-associated progressive multifocal leucoencephalopathy

Multiple Sclerosis

Volumn 16, Issue 6, 2010, Pages 749-753

  Kleiter, Ingo ^a   Schröder, Michael ^a   Lürding, Ralf ^a   Schuierer, Gerhard ^b   Clifford, David B ^c   Bogdahn, Ulrich ^a   Steinbrecher, Andreas ^a,d   Pöschl, Peter ^a  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^b University Medical Center   (Germany)

^c UNIVERSITY OF WASHINGTON   (United States)

^d HELIOS KLINIKUM ERFURT   (Germany)

Author keywords

Electroencphalography; MRI; Multiple sclerosis; Natalizumab; Progressive multifocal leucoencephalopathy

Indexed keywords

BETA1A INTERFERON; IMMUNOGLOBULIN; METHYLPREDNISOLONE; MIRTAZAPINE; MITOXANTRONE; NATALIZUMAB; PLACEBO; VIRUS DNA; MONOCLONAL ANTIBODY;

ADULT; ARTICLE; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; CLINICAL FEATURE; CONTRAST ENHANCEMENT; CORTICOSTEROID THERAPY; DISEASE ASSOCIATION; DISEASE COURSE; DRUG BLOOD LEVEL; DRUG DOSE REDUCTION; ELECTROENCEPHALOGRAPHY; EXPANDED DISABILITY STATUS SCALE; EYE EXAMINATION; FEMALE; HEMIANOPIA; HEMIPARESIS; HUMAN; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; IMMUNOADSORPTION; MULTIPLE SCLEROSIS; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC NEURITIS; OUTCOME ASSESSMENT; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; RELAPSE; VIRUS DETECTION; VISUAL DISORDER; BRAIN; BRAIN MAPPING; GENETICS; JC VIRUS; LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL; PATHOLOGY; VIROLOGY;

ADULT; ANTIBODIES, MONOCLONAL; ANTIBODIES, MONOCLONAL, HUMANIZED; BRAIN; BRAIN MAPPING; ELECTROENCEPHALOGRAPHY; FEMALE; HUMANS; JC VIRUS; LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL; MAGNETIC RESONANCE IMAGING; MULTIPLE SCLEROSIS;

EID: 77953745563     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1177/1352458510367718     Document Type: Article

References (10)

1. Major EO Progressive multifocal leukoencephalopathy in patients on immunomodulatory therapies. Annu Rev Med 2010 ; 61: 35-47.
2. Yousry TA, Major EO, Ryschkewitsch C., et al. Evaluation of patients treated with natalizumab for progressive multifocal leukoencephalopathy. N Engl J Med 2006 ; 354: 924-933.
3. Kappos L., Bates D., Hartung HP, et al. Natalizumab treatment for multiple sclerosis: recommendations for patient selection and monitoring. Lancet Neurol 2007 ; 6: 431-441.
4. Polman CH, OConnor PW, Havrdova E., et al. A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis. N Engl J Med 2006 ; 354: 899-910.
5. Linda H., von Heijne A., Major EO, et al. Progressive multifocal leukoencephalopathy after natalizumab monotherapy. N Engl J Med 2009 ; 361: 1081-1087.
6. Wenning W., Haghikia A., Laubenberger J., et al. Treatment of progressive multifocal leukoencephalopathy associated with natalizumab. N Engl J Med 2009 ; 361: 1075-1080.
7. Aksamit AJ Progressive multifocal leukoencephalopathy. Curr Treat Options Neurol 2008 ; 10: 178-185.
8. Krupp LB, Lipton RB, Swerdlow ML, et al. Progressive multifocal leukoencephalopathy: clinical and radiographic features. Ann Neurol 1985 ; 17: 344-349.
9. Farrell DF The EEG in progressive multifocal leukoencephalopathy. Electroencephalogr Clin Neurophysiol 1969 ; 26: 200-205.
10. Lima MA, Drislane FW, Koralnik IJ Seizures and their outcome in progressive multifocal leukoencephalopathy. Neurology 2006 ; 66: 262-264.